Abstract
Abstract The two common routes for administering a drug are inhalation and dermally. As administration of inhalants and dermal route drugs may result in adverse local and/or systemic effects, safety assessment of drugs with respect to the therapeutic‐to‐toxicity ratio are essential. This article focuses on both regulatory and technological considerations for safety assessment of inhalants and dermal route drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
